The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Cancer Communications
(Jan 2024)
Harnessing SARS‐CoV‐2‐specific CD8+ T cells to kill target tumor cells for cancer immunotherapy
Keunok Jung,
Deok‐Han Ko,
Jeong‐Yun Jang,
Young Rong Kim,
Jung Yeon Heo,
Yong‐Sung Kim
Affiliations
Keunok Jung
Department of Allergy and Clinical Immunology Ajou University School of Medicine Suwon Republic of Korea
Deok‐Han Ko
Department of Molecular Science and Technology Ajou University Suwon Republic of Korea
Jeong‐Yun Jang
Department of Molecular Science and Technology Ajou University Suwon Republic of Korea
Young Rong Kim
Department of Infectious Diseases Ajou University School of Medicine Suwon Republic of Korea
Jung Yeon Heo
Department of Infectious Diseases Ajou University School of Medicine Suwon Republic of Korea
Yong‐Sung Kim
Department of Allergy and Clinical Immunology Ajou University School of Medicine Suwon Republic of Korea
DOI
https://doi.org/10.1002/cac2.12497
Journal volume & issue
Vol. 44, no. 1
pp. 173 – 177
Abstract
Read online
No abstracts available.
WeChat QR code
Close